$384.91
0.02% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$384.91
+32.09 9.10% 1M
+49.37 14.71% 6M
+85.45 28.53% YTD
+90.95 30.94% 1Y
+129.76 50.86% 3Y
+181.81 89.52% 5Y
+293.01 318.84% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.06 0.02%
ISIN
US8636671013
Symbol
SYK
Sector

Key metrics

Market capitalization $146.73b
Enterprise Value $158.06b
P/E (TTM) P/E ratio 41.27
EV/FCF (TTM) EV/FCF 49.32
EV/Sales (TTM) EV/Sales 7.19
P/S ratio (TTM) P/S ratio 6.68
P/B ratio (TTM) P/B ratio 7.28
Dividend yield 0.79%
Last dividend (FY23) $3.05
Revenue growth (TTM) Revenue growth 10.51%
Revenue (TTM) Revenue $21.97b
EBIT (operating result TTM) EBIT $4.74b
Free Cash Flow (TTM) Free Cash Flow $3.21b
Cash position $4.68b
EPS (TTM) EPS $9.33
P/E forward 39.30
P/S forward 6.51
EV/Sales forward 7.02
Short interest 1.12%
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Stryker forecast:

22x Buy
67%
10x Hold
30%
1x Sell
3%

Analyst Opinions

33 Analysts have issued a Stryker forecast:

Buy
67%
Hold
30%
Sell
3%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
21,974 21,974
11% 11%
100%
- Direct Costs 8,509 8,509
8% 8%
39%
13,465 13,465
12% 12%
61%
- Selling and Administrative Expenses 6,288 6,288
12% 12%
29%
- Research and Development Expense 1,400 1,400
12% 12%
6%
5,777 5,777
12% 12%
26%
- Depreciation and Amortization 1,036 1,036
0% 0%
5%
EBIT (Operating Income) EBIT 4,741 4,741
15% 15%
22%
Net Profit 3,590 3,590
39% 39%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
FXEmpire
6 days ago
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
Neutral
PRNewsWire
7 days ago
FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care. In today's operating rooms, where precision and accuracy are critical, even th...
Neutral
PRNewsWire
12 days ago
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio.
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 52,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today